Oral MK8669 in Children/Adolescents with Solid Tumors (6-17 years)

Update Il y a 4 ans
Reference: EUCTR2011-000729-55

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

• To identify the dose limiting toxicities (DLT) and maximum tolerated dose (MTD) of ridaforolimus when administered to children from 6 to less than 18 years of age with advanced solid tumours. • To characterize the pharmacokinetics(levels of study drug in the blood) of ridaforolimus when administered to children from 6 to less than 18 years of age with advanced solid tumours.


Inclusion criteria

  • Advanced solid tumours including lymphoma and tumours of the central nervous system

Links